Issuing a draft list of revised risk-based classification of cardiovascular and neurological devices, the Central Drugs ...
The trial is designed to assess the safety and effectiveness of Avisi Technologies' investigational VisiPlate device in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback